Notably, PDGFRA-mutant GISTs are characterized by the strongest immune-signature and immune-pathway enrichment compared to other GIST molecular subtypes, including KIT mutant and SDH-deficient GISTs [23,24,25]. This evidence concerns the gene PDGFRA and gastrointestinal stromal tumor.